CHRNA7 and arthritic joint disease: It has been shown that treatment with α7nAChR agonist improved arthritis scores in animal models of rheumatoid arthritis whereas α7nAChR knock-out mice showed worse disease outcome suggesting its therapeutic potential (Figure 4B) (160, 161).